Zentalis Pharmaceuticals, Inc. Quarterly Current Ratio in % from Q3 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Zentalis Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q3 2020 to Q2 2024.
  • Zentalis Pharmaceuticals, Inc. Current Ratio for the quarter ending June 30, 2024 was 788 %, a 7.28% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 788 -61.9 -7.28% Jun 30, 2024
Q1 2024 891 +73.5 +8.99% Mar 31, 2024
Q4 2023 846 +29.8 +3.66% Dec 31, 2023
Q3 2023 874 +56.6 +6.93% Sep 30, 2023
Q2 2023 850 -3.24 -0.38% Jun 30, 2023
Q1 2023 818 +14.1 +1.75% Mar 31, 2023
Q4 2022 816 -48.5 -5.61% Dec 31, 2022
Q3 2022 817 -142 -14.8% Sep 30, 2022
Q2 2022 853 -227 -21% Jun 30, 2022
Q1 2022 804 -448 -35.8% Mar 31, 2022
Q4 2021 864 -338 -28.1% Dec 31, 2021
Q3 2021 959 -87.6 -8.37% Sep 30, 2021
Q2 2021 1.08K Jun 30, 2021
Q1 2021 1.25K Mar 31, 2021
Q4 2020 1.2K Dec 31, 2020
Q3 2020 1.05K Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.